Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) FCF Margin (2024 - 2025)

Historic FCF Margin for Zenas BioPharma (ZBIO) over the last 2 years, with Q1 2025 value amounting to 370.69%.

  • Zenas BioPharma's FCF Margin changed N/A to 370.69% in Q1 2025 from the same period last year, while for Sep 2025 it was 1057.1%, marking a year-over-year change of. This contributed to the annual value of 2396.1% for FY2024, which is 23350100.0% down from last year.
  • Zenas BioPharma's FCF Margin amounted to 370.69% in Q1 2025.
  • Zenas BioPharma's FCF Margin's 5-year high stood at 370.69% during Q1 2025, with a 5-year trough of 772.56% in Q4 2024.